During this unprecedented time of fear and uncertainty, we witness daily the incredible sacrifices of healthcare professionals, EMS, military, law enforcement, and others working tirelessly to keep patients healthy and save lives. We have witnessed people coming together to support each other in any way possible, around the globe. This has become increasingly difficult with…
NHIA and 250+ stakeholders urge CMS to overhaul home infusion rules “The National Home Infusion Association (NHIA) and more than 250 leading patient advocacy organizations, pharmacy groups, physician specialty societies, home infusion providers, and other stakeholders are urging the Centers for Medicare & Medicaid Services (CMS) to revisit their flawed interpretation of Medicare’s home infusion…
Intravenous immune globulin (IVIG) shortage affects large commercial and independent specialty pharmacies across the country As an independently owned specialty pharmacy, OptionOne collaborates with pharma manufacturers, distribution centers and medical providers to address the widespread intravenous immune globulin (IVIG) shortage. These national shortages significantly impact patients across the country, including right here in Oklahoma. Patients…
NHIA Position Paper: Home Infusion Reimbursement Must Reflect Essential Specialized Pharmacy Professional Services Due to recent legislation and an unduly restrictive rule issued by the Centers for Medicare and Medicaid Services (CMS), the National Home Infusion Association (NHIA) “believes Medicare patients will not be able to access home infusion services and will have to seek…
National Home Infusion Association (NHIA) to Sue CMS Over Medicare Transitional Payment From NHIA – Alexandria, VA – February 15, 2019 – Yesterday, the National Home Infusion Association (NHIA) filed a lawsuit against the U.S. Department of Health and Human Services (HHS) over a misguided policy determination that could significantly reduce patients’ access to home infusion…
Early this morning, Congress passed legislation to allow transitional reimbursement for the clinical services that are integral to home infusion therapy under Medicare Part B. Providers of home and specialty infusion therapy and the Medicare beneficiaries they serve have been advocating for this much-needed remedy for the past year. This action by Congress addresses a severe gap…
Yesterday, Senator Isakson (R-GA) during a Finance Committee Hearing regarding the President’s Fiscal Year 2018 Budget had the opportunity to discuss home infusion with Secretary of Health and Human Services Price. Isakson noted his personal story regarding home infusion and pressed on the need for a services and supplies payment for Part D home infusion…
Research now suggests a link exists between well-educated and informed patients and cheaper health care. ModernHealthCare.com recently posted an article boasting findings from Health Affairs Magazine discussing the effects of informed patients on the healthcare budget claiming, “Patients with the highest scores on a self-reporting survey of ‘knowledge, skills, and confidence’ to make healthy choices…
Medicare’s refusal to pay for home infusion services, like virtually every private payer does, is unacceptable. This dilemma forces many Medicare patients to receive infusion drugs in the hospital, where care is much more expensive and the risk of infection is greater. Help us spread the word that it’s time for Medicare to make a…
In this article in the Huffington Post, Mary Ann Cope details a scenario that we at OptionOne encounter on a daily basis: patients on Medicare want to receive their infusion at home, but Medicare is unwilling to follow the way of nearly every major payer and pay for infusion of most drugs in the home.…